Non‐vitamin‐K‐antagonist oral anticoagulants vs placebo
Apixaban (all doses combined) vs placebo · adults after AMI without an indication for anticoagulation
3 findings from 1 review
- Non‐vitamin‐K‐antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta‐analysis 2024 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 8638 participantsModerate
- Non‐vitamin‐K‐antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta‐analysis 2024 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 8638 participantsModerate
- Non‐vitamin‐K‐antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta‐analysis 2024 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 8544 participantsHigh